Candida is a yeast species recognized as the most frequent etiological agent of systemic and invasive thrush in humans. Invasions can affect all tissues, organs and systems of human in various stages of development. In the last 10 years Candida infections have increased 15 times. The purpose of our study was to determine the sensitivity of four antibiotics belonging to three different groups of antifungal agents against clinical and food-borne Candida strains. Our studies showed that of all tested strains, 7% was resistant to nystatin, 32% to fluconazole, 23% to voriconazole, and no strains grew in the presence of caspofungin. Despite the differences in biochemical profiles of clinical and food-borne isolates of Candida, a group of strains showing resistance to antibiotics include both types of isolates. At the same time circulating of antibiotic-resistant strains outside the hospital environment and the yeast infection via food is possible.
INTRODUCTION
Candida yeasts are natural inhabitants of the alimentary, genital and upper respiratory tracts of mammals (Szczepaniak et al., 2004; Tunka et al., 2006) . Approximately 40-60% of people are carriers of Candida, however, it does not mean that the clinical Candidiasis occurs (Ibanez-Nolla et al., 2004) . Candida is recognized as the most frequent etiological agent of systemic and invasive thrush in humans among which the most common is Candida albicans (80-90%). Invasions can affect all tissues, organs and systems of human in various stages of development. Probability of infections is growing with specific conditions of the organism and in particular during predisposing situations, like: diabetes, pregnancy, use of antibiotics, cortisones, contraceptives, estrogens, immunosuppresors, methronidozol, genetic factors, etc. (Tunka et al., 2006; Torba et al., 2012; Silva et al., 2012) . In the past ten years, Candida infections have increased 15 times (Kenedy & Wolz, 2007; Torba et al., 2012) .
The discovery and development of antibiotics for the treatment of microorganisms infections was one of the most significant medical achievements of the twentieth century. Nowadays, at least a few hundred of antibiotics are known, but this does not mean a sense of security. Having the vast number of drugs, which at the time of entry into treatment were completely new agents, we used them fairly lightly. In last few years, among factors contributing to fungal colonization, use of antibiotics with broad spectrum of antibacterial activity is the most significant. According to statistics from the monitoring of antibiotic consumption of European Surveillance of Antibiotic Consumption, Poland is in the top ten among European countries in terms of quantitative antibiotic consumption per capita (Dzierżanowska, 2001; Kostecka, 2011) . Unfortunately, many of existing antimicrobial agents are under threat from the widespread emergence of microorganisms resistance (Kuźma et al, 2007; Deptuła & Gospodarek, 2010) . This huge number of resistant species is mainly caused by abuse of all antibiotics in the treatment and also in the treatment of viral infections (Dzierżanowska, 2001 , Lewis & Ausubel, 2006 Straus & Hancock, 2006; Kaufman, 2011) . Antibiotic-resistant strains of Candida circulate in human environment and colonize diverse environment, they get also into the food. Highly-processed food is not generally contaminated with yeasts of the Candida genus. However, the food products, fermented products and products with a low degree of processing are not free from these yeasts. The presence of the yeast in the food is well documented (Tornai-Lehoczki et al., 2003; Tyrer et al., 2004; Bajpai et al., 2011) , but only few works concern the study of antibiotic resistance of food-borne isolates.
Within the presented study the sensitivity of both clinical and food-borne Candida strains against antibiotics belonging to three different groups was determined. The following antibiotics were used: nystatin (polyenes), fluconazole and voriconazole (triazoles I and II generation, respectively) and caspofungin (echinocandins). Biochemical properties. API 20C AUX tests (bioMerieux, France) were used for biochemical characteristics of the yeast. All procedures were conducted according to manufacturer recommendation. The biochemical profiles of Candida isolates were estimated according to the yeast abilities to assimilate 19 substrates: glucose, glycerol, 2-keto-D-gluconate, L-arabinose, D-xylose, adonitol, xylitol, galactose, inositol, sorbitol, α-methyl-D-glucoside, N-acetyl-D-glucosamine, cellobiose, lactose, maltose, sucrose, trehalose, melezitoze, raffinose.
MATERIALS AND METHOD
Antibiotics. The following antibiotics were used: 3,4,7,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo-nonatriaconta-19,21, 25,27,29,31-hexaene-36-carboxylic acid) at the concentration of 50 µg/mL (PPH Galfarm Sp z o.o., Polska). Antifungal activity assessment. Agar disc diffusion method was used for screening of antifungal activity of each antibiotic. Yeast inoculum (10 3 cfu/mL) in 0.85% NaCl solution was spread on the surface of YPG agar plate. Sterile filter paper discs (6mm in diameter) with 50 µg of nystatin, 25 µg of fluconazole, 1 µg of voriconazol and with 10 μl of caspofungin acetate in the concentration of 5 µg/ ml were placed on the inoculated plates. The positive control consisted of water instead of antibiotics, while uninoculated plates con- taining antibiotics served as a negative control. All plates were incubated for 48 h at 37ºC. Size of inhibition zone diameters surrounding filter paper disc was measured and compared to the Zone Diameter Interpretive Standards (Table 2) . Statistical analysis. Hierarchical cluster analysis was used to estimate the similarity of Candida strains according to their biochemical profiles and susceptibility to antibiotics. Outcomes of biochemical properties were displayed as binary data, 0 or 1 when the feature was absent or present in the yeast profile, respectively. Whereas the results of yeasts antibiotic-sensitivity were presented as the average value of growth inhibition zones diameter for each examined antibiotic. The algorithm for hierarchical clustering was calculated by Ward's method (Statistica 6.0, Stat Soft Inc.) and cluster hierarchy was presented using a tree structure (dendrogram) with horizontal agglomeration distance.
Statistic development zones of inhibition. Diameter zone of growth inhibition is presented as average value of four measurements and standard deviations were calculated (Microsoft Excel 2010).
RESULTS AND DISCUSSION
Most of 26 clinical strains used in researches were isolated from the faeces (61%), vagina (11%) and throat (11%). C. albicans was predominated in this group and only two isolates were identified as C. glabrata and C. lusitaniae. Pickled cucumbers (39%) and fruit yoghurt (28%) were the main source of food-borne Candida. C. lusitaniae and C. krusei represented the largest number of isolates. Neither C. albicans nor C. glabrata typically isolated from human were not found in food. The only genus isolated from these two sources simultaneously was C. lusitaniae.
Hierarchical cluster analysis applied for similarity assessment of Candida isolates according to their biochemical profiles showed differentiation of the strains in the two clusters (Fig. 1) . The first cluster includes 24 clinical strains of C. albicans and foodborne C. tropicalis (fo/BM/01) isolated from pickled cucumbers. The second cluster, except 17 strains originating from food matrices, includes two clinical strains C. glabrata (cl/KL/01) and C. lusitaniae (cl/KL/02). At the same time, distinct biochemical heterogeneity was stated among the isolates of C. albicans. It is probably conditioned by an adaptation of the yeast to host organism.
Candida isolates were evaluated for sensitivity to four antibiotics. All isolates were found sensitive to caspofungin that was expressed by growth inhibition zones ranged from 18 to 49 mm. Caspofungin is a valuable fairly new antifungal agent with a novel mechanism of action belonging to the class echinocandins (McCormack & Perry, 2005; Wieczorek et al., 2008) . In the early 2000's, echinocandins were licensed for the treatment and prevention of fungal infections (Finkelman, 2010; Al-Badriyeh et al., 2012; Lobo et al., 2013) . Spectrum of caspofungin activity is relatively broad including Candida and Aspergillus species, and mycelial forms of endemic fungi (Wieczorek et al., 2008; Wiederhold & Herrera, 2012) . The high effectiveness of this antibiotic is attributed to an inhibition of the glucan synthase complex in yeast cells, that is why it is an attractive tar- Table 3 were sensitive to all antibiotics tested.
get due to the lack of homologous enzymes in human cells (Dominguez-Gil et al., 2007; Marchettia et al., 2007; Wieczorek et al., 2008) . Caspofungin is mainly used in hospital treatment, so it is possible that the yeast had not yet developed resistance systems to this antibiotic and are still sensitive. Due to different sensitivity to nystatin, fluconazole and voriconazole 15 strains were grouped together (Table 3).
Triazoles, which did not totally inhibit growth of the clinical isolates and only against five food-borne strains showed the lowest effectiveness. Azoles were introduced to the therapy in the 1980s. Mechanism of these drugs action is impaired synthesis of ergosterol in the fungal plasma membrane, with the participation of cytochrome P450. Voriconazole also inhibits the synthesis of chitin (Pfaller et al., 2003 , Cuenca-Estrella et al., 2005 Szymankiewicz & Dancewicz, 2008) . Similar mechanism of action can explain the similarity of activity against tested Candida strains. Triazoles, particularly fluconazole, are firstline drugs in the treatment of fungal infections. Spectrum of activity of fluconazole does not include infections caused by Candida glabrata and Candida krusei (Pfaller et al., 2003; Cuenca-Estrella et al., 2005; Spelberg et al., 2006; Szymankiewicz & Dancewicz, 2008) . However, in our study, two food-borne strains of C. krusei showed a susceptibility to fluconazole, while the third one was intermediate. There were no resistant strains of C. krusei to fluconazole. Only one clinical isolate of C. glabrata was tested on the activity of antibiotics and it was not sensitive to fluconazole. Voriconazole is a triazole of the second generation. It is used for invasive Candida infections caused by strains resistant to fluconazole. This antibiotic shows a strong activity against Candida including C. krusei and C. glabrata (Pfaller et al., 2003; Cuenca-Estrella et al., 2005; Panackal et al., 2006; Spelberg et al., 2006; Szymankiewicz & Dancewicz, 2008) . In our research, voriconazole effectively inhibited growth of C. krusei, however, C. glabrata was not sensitive neither to fluconazole nor to voriconazole.
Three isolates were resistant to nystatin: one C. albicans clinical strain isolated from faeces and two foodborne strains C. tropicalis and C. pelliculosa isolated from pickled cucumber and animal feed respectively. Nystatin inhibited growth of 93% of all the tested strains. Figure 2 shows representative examples of plates illustrating action of antibiotics on Candida isolates.
According to Ng et al., 2003 it has been proved to be the most effective agents in the treatment of various fungal infections. In the study of Hossain et al., 2000 was shown that nystatin was effective against some fungal pathogens unresponsive to amphotericin B and azoles. Pharmacological activity of nystatin comes from the interaction with ergosterol found in the plasma membrane of fungal cells with subsequent functional disorder of the membrane, resulting in yeast death (Barăo de Aguiar et al., 2010) . Unfortunately, the toxicities caused by polyene antibiotics limit their use (Ng et al., 2003; Hossain et al., 2000; Chandrasekar, 2011; Semis et al., 2012) . Nystatin is not absorbed through the skin or from the gastrointestinal track, and so topical and oral administration of nystatin is not associated with significant toxicities (Hossain et al., 2000; Ng et al., 2003; Chandrasekar, 2011; Semis et al., 2012) . That is why it was used as the first-choice drug for the treatment of oral candidiasis (Barâo de Aguiar et al., 2010) . In Poland, this antibiotic was widely used during antibioticotheraphy in bacterial infection as a prophylaxis of gastrointestinal candidiasis. Reduced nystatin consumption in the recent years, especially in the prophylactic treatment of fungal infection, could be the reason of sensitivity recovering fungi of recovered its resistance to this antibiotic. The only one resistant strain for voriconazole, fluconazole and nystatin was C. albicans (cl/MP/01) isolated from the faeces.
Similarity of Candida isolates according to their sensitivity to different antibiotics is shown in Fig. 3 . Eleven of the 15 isolates showed a resistance or at least intermediate sensitivity to one antibiotic tested form cluster significantly different from the other strains. C. albicans are the majority (64%) in this cluster. As in the case of biochemical profiles, food-borne C. tropicalis strains (fo/ BM/01) showed high homology with the clinical strains.
CONCLUSIONS
Among 44 Candida strains tested, neither C. albicans nor C. glabrata typically isolated from human, were not found in food. However, according to biochemical profiles C. albicans isolates were distinct from the foodborne ones, a substantial heterogeneity within this group was also noted. Simultaneously, the incidents of biochemical profiles conformity of some clinical and foodborne isolates may be a result of Candida transmission via food. The presented research shows that a group of strains expressing intermediate sensitivity or resistance to the tested antibiotics include both types of isolates. At the same time, the similarity of food-borne C. tropicalis to the clinical strains of C. albicans does not exclude the possibility of circulating of antibiotic-resistant strains outside the hospital environment and the yeast infection entered into the body with food. Local monitoring the resistance of environmental Candida strains will be helpful in making strategic decisions on the use of specific drugs in therapy.
